Delivery Order SPE2DX22D0010-SPE2D826FCD01
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $24,245.78 for Percocet tablets (10/325 mg) on December 22, 2025, with completion targeted for December 23, 2025. This competitively awarded, non-set-aside contract employs firm fixed-price pricing and represents a child award under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $27,558.32 delivery order to AmerisourceBergen Drug Corp for Percocet tablets (10/325 mg) under a firm fixed-price contract. The award, announced on September 4, 2025, represents a competitive procurement with an ultimate completion date of September 5, 2025. This delivery order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations. No set-aside...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Percocet tablets (10/325 mg) valued at $9,710.48. This firm fixed-price, non-set-aside delivery order is scheduled for completion by November 4, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Percocet tablets (10/325 mg) with a ceiling value of $40,640.81. This firm fixed-price delivery order, with an ultimate completion date of October 21, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Percocet tablets (10/325 mg) with a ceiling value of $41,430.55 under a firm fixed-price contract. The award was made on April 24, 2025, with an ultimate completion date of April 25, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Percocet tablets (10/325 mg) with a ceiling value of $20,054.90. This firm fixed-price delivery order, which must be completed by August 28, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Percocet Tablets (10/325 mg) with a ceiling value of $23,778.44. This competitively awarded, firm fixed-price delivery order is classified as a child contract and represents a non-set-aside procurement. The place of performance is located at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 29,...
- The Defense Logistics Agency's Medical Supply Chain awarded a $21,399.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for Percocet Tablets (10/325 mg) on October 6, 2025, with completion targeted for October 7, 2025. This is an unset-aside, competitively awarded delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 13, 2025, for the supply of Percocet tablets (10/325 mg) with a ceiling value of $13,210.51. This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The U.S. Defense Department's Medical Supply Chain awarded a $6,403.30 delivery order to AmerisourceBergen Drug Corp for Percocet tablets (5/325 mg) with a completion date of October 31, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCD01Delivery Order
The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Percocet tablets (10/325 mg) under a firm fixed-price contract valued at $8,267.43. The order was awarded on January 2, 2026, with an ultimate completion date of January 5, 2026, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support program enabling AmerisourceBergen to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems worldwide. The Percocet order represents a routine pharmaceutical requirement within this larger strategic partnership supporting Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 1/1/26 |